Results 11 to 20 of about 48,810 (253)
Phenotypes and karyotypes of human malignant mesothelioma cell lines. [PDF]
BackgroundMalignant mesothelioma is an aggressive tumour of serosal surfaces most commonly pleura. Characterised cell lines represent a valuable tool to study the biology of mesothelioma. The aim of this study was to develop and biologically characterise
Vandana Relan +13 more
doaj +2 more sources
Malignant Peritoneal Mesothelioma Diagnosed by a Laparoscopy : A Case Report [PDF]
Malignant mesothelioma is rare, and its prognosis is markedly poor. It is often difficult to distinguish malignant mesothelioma from carcinomatous peritonitis of other solid tumors.
品川, 真奈花 +10 more
core +1 more source
Geographic distribution of malignant mesothelioma incidence and survival in Australia [PDF]
Objectives: To understand the geographic distribution of and area-level factors associated with malignant mesothelioma incidence and survival in Australia.
Cameron, Jessica K. +15 more
core +1 more source
Malignant mesothelioma (MM) is a rare tumor of mesothelial cells, with an increasing incidence both in developed and developing countries. MM has three major histological subtypes, in order of frequency, according to the World Health Organization (WHO ...
Anita Sejben +5 more
doaj +1 more source
Mesothelioma is a malignant tumour of the pleura or peritoneum caused by asbestos. It is increasing in frequency and the prognosis remains grim, with average survival around 1 year.Medical literature and personal experience.Amphibole fibres are far more potent than chrysotile in causing mesothelioma.A minority view suggests that mesotheliomas in those ...
openaire +4 more sources
Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study. [PDF]
BACKGROUND: The effects of extra-pleural pneumonectomy (EPP) on survival and quality of life in patients with malignant pleural mesothelioma have, to our knowledge, not been assessed in a randomised trial.
Kilburn, L.S. +59 more
core +1 more source
Malignant pleural mesothelioma [PDF]
The incidence of malignant pleural mesothelioma (MPM) has risen for some decades and is expected to peak between 2010 and 2020. Up to now, no single treatment has been proven to be effective and death usually occurs within about 12-17 months after diagnosis. Perhaps because of this poor prognosis, early screening has incited little interest.
P, Baas, H, Schouwink, F A, Zoetmulder
openaire +4 more sources
Diffuse pulmonary metastasis secondary to primary peritoneal malignant mesothelioma is rarely reported in the literature. In this report we describe a 59-year-old Caucasian women with no known previous asbestos exposure presenting with bilateral diffuse ...
Madeleine Haygarth +5 more
doaj +1 more source
Malignant Mesothelioma (MM) is a rare but rapidly fatal and aggressive tumor of the pleura and peritoneum with limited knowledge of its natural history. The incidence has increased in the past two decades but still it is a rare tumor. Etiology of all forms of mesothelioma is strongly associated with industrial pollutants, of which asbestos is the ...
Ishtiaq, Ahmed +2 more
openaire +2 more sources
Unusually Aggressive Presentation of Malignant Peritoneal Mesothelioma: Two Case Reports [PDF]
Malignant peritoneal mesothelioma is a rare disease. Patients mainly present with abdominal distension, pain, nausea, and weight loss with or without an exposure history of asbestos.
Dominik Neff +9 more
core +1 more source

